Literature DB >> 8299120

Soluble factors produced by macrophages/monocytes inhibit lymphokine-activated killer activity in rat splenocyte cultures.

P J Kuppen1, A M Eggermont, R B Quak, A Marinelli, C J van de Velde, G J Fleuren.   

Abstract

In the present study we investigated the inhibition of interleukin-2(IL-2)-induced lymphokine-activated killer (LAK) activity in rat splenocyte cultures in relation to the presence of 2-mercaptoethanol and macrophages/monocytes. The presence of 2-mercaptoethanol is necessary for induction of LAK activity in rat splenocyte cultures. Removal of macrophages/monocytes from rat splenocytes by plastic or nylon-wool adherence, or iron ingestion resulted in LAK induction by IL-2 in the absence of 2-mercaptoethanol. The effect of macrophages/monocytes on LAK activity was also studied in transwell co-cultures. In the absence of 2-mercaptoethanol, the induction of LAK activity was very low in macrophage/monocyte-depleted splenocytes with macrophages/monocytes in the upper compartment of a transwell culture. In contrast, in the presence of 2-mercaptoethanol a high level of LAK activity was induced in these transwell cultures, showing that 2-mercaptoethanol abolished the LAK-inhibiting capacity of macrophages/monocytes. In addition, established LAK activity was strongly inhibited when, after LAK induction, splenocytes were cultured with supernatant of unfractionated splenocytes, which were cultured with IL-2 but in the absence of 2-mercaptoethanol. Addition of 2-mercaptoethanol abrogated the inhibiting effect of the supernatant completely. These experiments demonstrate that rat macrophages/monocytes produce 2-mercaptoethanol-sensitive soluble LAK-inhibiting factors. Ultrafiltration of conditioned culture medium of macrophages/monocytes revealed the presence of LAK-inhibiting factors larger than 10 kDa. We concluded that 2-mercaptoethanol-sensitive soluble factors produced by macrophages/monocytes determine the level of LAK induction in rat splenocyte cultures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299120     DOI: 10.1007/BF01517171

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  35 in total

1.  Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patients.

Authors:  K Itoh; N R Pellis; C M Balch
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Macrophage content of tumours in relation to metastatic spread and host immune reaction.

Authors:  S A Eccles; P Alexander
Journal:  Nature       Date:  1974-08-23       Impact factor: 49.962

3.  Immune responses in vitro. IV. A comparison of the protein-free and mouse serum-supplemented mouse mixed lymphocyte interaction assays.

Authors:  A B Peck; E Katz-Heber; R E Click
Journal:  Eur J Immunol       Date:  1973-08       Impact factor: 5.532

4.  Pharmacologic modulation of arachidonic acid metabolism in man. A minireview with emphasis on radioimmunological methods used to quantitate drug effects.

Authors:  C Patrono; P Patrignani
Journal:  Int J Immunopharmacol       Date:  1982

5.  Function of 2-mercaptoethanol as a macrophage substitute in the primary immune response in vitro.

Authors:  H Lemke; H G Opitz
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

6.  The effects of mercaptoethanol and of peritoneal macrophages on the antibody-forming capacity of nonadherent mouse spleen cells in vitro.

Authors:  C Chen; J G Hirsch
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

7.  Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine.

Authors:  H Gmünder; H P Eck; B Benninghoff; S Roth; W Dröge
Journal:  Cell Immunol       Date:  1990-08       Impact factor: 4.868

8.  The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531.

Authors:  P J Kuppen; A M Eggermont; K M Smits; J D van Eendenburg; S P Lazeroms; C J van de Velde; G J Fleuren
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

9.  Lymphokine-activated killer cells. Analysis of progenitors and effectors.

Authors:  J R Ortaldo; A Mason; R Overton
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

10.  Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2.

Authors:  A M Eggermont; E P Steller; W Matthews; P H Sugarbaker
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

View more
  1 in total

1.  The role of the spleen, especially regarding changes in both thromboxane A2 and the remnant liver dysfunction after extensive hepatectomy.

Authors:  M Kitagawa; K Tanigawa; M Iwata
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.